等待开盘 09-26 09:30:00 美东时间
-0.630
-1.02%
今日重点评级关注:HC Wainwright & Co.:维持Astria Therapeutics"买入"评级,目标价从16美元升至20美元;HC Wainwright & Co.:维持Avalo Therapeutics"买入"评级,目标价从15美元升至25美元
09-18 10:13
Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:CMPR) with a Buy and raises the price target from $74 to $78.
09-17 22:52
Cimpress shares are trading higher after the company reported better-than-expec...
07-30 04:37
Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and maintains $65 price target.
07-29 20:58
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is projected to repor...
07-29 16:32
Cimpress NV ( ($CMPR) ) has released its Q2 earnings. Here is a breakdown of th...
01-31 11:55
Oppenheimer:上调Ovid Therapeutics(OVID)评级至"跑赢大市",目标价4美元
01-30 16:06
Cimpress (NASDAQ:CMPR) released its Q2 earnings on Wednesday, January 29, 2025 ...
01-30 05:36
The earnings results for Cimpress (NASDAQ:CMPR) for Q2 were made public on Wedn...
01-30 05:30